HEADER TRANSFERASE 15-APR-15 4ZZZ TITLE STRUCTURE OF HUMAN PARP1 CATALYTIC DOMAIN BOUND TO AN ISOINDOLINONE TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY [ADP-RIBOSE] POLYMERASE 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 665-1014; COMPND 5 SYNONYM: PARP-1, ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE 1, COMPND 6 ARTD1, NAD(+) ADP-RIBOSYLTRANSFERASE 1, ADPRT 1, POLY[ADP-RIBOSE] COMPND 7 SYNTHASE 1; COMPND 8 EC: 2.4.2.30; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: NEB T7 EXPRESS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: PET28A KEYWDS TRANSFERASE, HUMAN PARP1, ARTD1 EXPDTA X-RAY DIFFRACTION AUTHOR E.CASALE,M.FASOLINI,G.PAPEO,H.POSTERI,D.BORGHI,A.A.BUSEL,F.CAPRERA, AUTHOR 2 M.CIOMEI,A.CIRLA,E.CORTI,M.DANELLO,M.FASOLINI,E.R.FELDER,B.FORTE, AUTHOR 3 A.GALVANI,A.ISACCHI,A.KHVAT,M.Y.KRASAVIN,R.LUPI,P.ORSINI,R.PEREGO, AUTHOR 4 E.PESENTI,D.PEZZETTA,S.RAINOLDI,F.RICCARDISIRTORI,A.SCOLARO,F.SOLA, AUTHOR 5 F.ZUCCOTTO,D.DONATI,A.MONTAGNOLI REVDAT 4 08-MAY-24 4ZZZ 1 REMARK REVDAT 3 06-MAR-19 4ZZZ 1 REMARK REVDAT 2 23-SEP-15 4ZZZ 1 JRNL REVDAT 1 12-AUG-15 4ZZZ 0 JRNL AUTH G.M.E.PAPEO,H.POSTERI,D.BORGHI,A.A.BUSEL,F.CAPRERA,E.CASALE, JRNL AUTH 2 M.CIOMEI,A.CIRLA,E.CORTI,M.D'ANELLO,M.FASOLINI,B.FORTE, JRNL AUTH 3 A.GALVANI,A.ISACCHI,A.KHVAT,M.Y.KRASAVIN,R.LUPI,P.ORSINI, JRNL AUTH 4 R.PEREGO,E.PESENTI,D.PEZZETTA,S.RAINOLDI,F.RICCARDI-SIRTORI, JRNL AUTH 5 A.SCOLARO,F.SOLA,F.ZUCCOTTO,E.R.FELDER,D.DONATI,A.MONTAGNOLI JRNL TITL DISCOVERY OF JRNL TITL 2 2-[1-(4,4-DIFLUOROCYCLOHEXYL) JRNL TITL 3 PIPERIDIN-4-YL]-6-FLUORO-3-OXO-2, JRNL TITL 4 3-DIHYDRO-1H-ISOINDOLE-4-CARBOXAMIDE (NMS-P118): A POTENT, JRNL TITL 5 ORALLY AVAILABLE AND HIGHLY SELECTIVE PARP- 1 INHIBITOR FOR JRNL TITL 6 CANCER THERAPY. JRNL REF J.MED.CHEM. V. 58 6875 2015 JRNL REFN ISSN 0022-2623 JRNL PMID 26222319 JRNL DOI 10.1021/ACS.JMEDCHEM.5B00680 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 96.7 REMARK 3 NUMBER OF REFLECTIONS : 59426 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.230 REMARK 3 R VALUE (WORKING SET) : 0.228 REMARK 3 FREE R VALUE : 0.265 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3161 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.95 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4272 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.62 REMARK 3 BIN R VALUE (WORKING SET) : 0.2910 REMARK 3 BIN FREE R VALUE SET COUNT : 234 REMARK 3 BIN FREE R VALUE : 0.3290 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5456 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 74 REMARK 3 SOLVENT ATOMS : 146 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.29 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.29000 REMARK 3 B22 (A**2) : 1.48000 REMARK 3 B33 (A**2) : -0.57000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.47000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.175 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.160 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.126 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.323 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.942 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.925 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5629 ; 0.011 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7596 ; 1.519 ; 1.995 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 688 ; 6.227 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 238 ;38.216 ;25.084 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1039 ;18.506 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;17.000 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 852 ; 0.106 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4128 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 4ZZZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-APR-15. REMARK 100 THE DEPOSITION ID IS D_1290063606. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.95 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 62636 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 200 DATA REDUNDANCY : 2.600 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.37000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2M AMMONIUM SULFATE, 2% PEG400 0.1 M REMARK 280 TRIS PH 8.0, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 89.95000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.02500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 89.95000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 27.02500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3340 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 31250 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -71.5 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 653 REMARK 465 PRO A 654 REMARK 465 LEU A 655 REMARK 465 THR A 656 REMARK 465 VAL A 657 REMARK 465 ASN A 658 REMARK 465 PRO A 659 REMARK 465 GLY A 660 REMARK 465 THR A 661 REMARK 465 ASP A 784 REMARK 465 SER A 785 REMARK 465 SER A 786 REMARK 465 GLY B 653 REMARK 465 PRO B 654 REMARK 465 LEU B 655 REMARK 465 THR B 656 REMARK 465 VAL B 657 REMARK 465 ASN B 658 REMARK 465 PRO B 659 REMARK 465 GLY B 660 REMARK 465 THR B 661 REMARK 465 LYS B 662 REMARK 465 SER B 663 REMARK 465 SER B 782 REMARK 465 ASP B 783 REMARK 465 ASP B 784 REMARK 465 SER B 785 REMARK 465 SER B 786 REMARK 465 LYS B 787 REMARK 465 SER B 1012 REMARK 465 LEU B 1013 REMARK 465 TRP B 1014 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 841 NE - CZ - NH1 ANGL. DEV. = 4.2 DEGREES REMARK 500 ARG A 841 NE - CZ - NH2 ANGL. DEV. = -4.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 677 51.32 -96.99 REMARK 500 HIS A 826 58.16 -94.96 REMARK 500 ASP A 914 77.77 -163.31 REMARK 500 GLN A 996 1.56 -67.86 REMARK 500 ASP B 678 98.24 -62.02 REMARK 500 LYS B 798 48.59 39.39 REMARK 500 HIS B 826 57.99 -97.68 REMARK 500 ILE B 834 -54.24 -133.48 REMARK 500 ALA B 880 150.66 -49.95 REMARK 500 ASP B 981 54.64 -93.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PHE B 744 GLY B 745 -42.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 2012 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 2015 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 2016 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 2017 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 2018 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 2013 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 2014 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FSU A 2019 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FSU B 2015 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4ZZX RELATED DB: PDB REMARK 900 STRUCTURE OF PARP2 CATALYTIC DOMAIN BOUND TO AN ISOINDOLINONE REMARK 900 INHIBITOR REMARK 900 RELATED ID: 4ZZY RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN PARP2 CATALYTIC DOMAIN BOUND TO AN ISOINDOLINONE REMARK 900 INHIBITOR REMARK 900 RELATED ID: 5A00 RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN PARP1 CATALYTIC DOMAIN BOUND TO AN ISOINDOLINONE REMARK 900 INHIBITOR DBREF 4ZZZ A 655 1014 UNP P09874 PARP1_HUMAN 655 1014 DBREF 4ZZZ B 655 1014 UNP P09874 PARP1_HUMAN 655 1014 SEQADV 4ZZZ GLY A 653 UNP P09874 EXPRESSION TAG SEQADV 4ZZZ PRO A 654 UNP P09874 EXPRESSION TAG SEQADV 4ZZZ GLY B 653 UNP P09874 EXPRESSION TAG SEQADV 4ZZZ PRO B 654 UNP P09874 EXPRESSION TAG SEQRES 1 A 362 GLY PRO LEU THR VAL ASN PRO GLY THR LYS SER LYS LEU SEQRES 2 A 362 PRO LYS PRO VAL GLN ASP LEU ILE LYS MET ILE PHE ASP SEQRES 3 A 362 VAL GLU SER MET LYS LYS ALA MET VAL GLU TYR GLU ILE SEQRES 4 A 362 ASP LEU GLN LYS MET PRO LEU GLY LYS LEU SER LYS ARG SEQRES 5 A 362 GLN ILE GLN ALA ALA TYR SER ILE LEU SER GLU VAL GLN SEQRES 6 A 362 GLN ALA VAL SER GLN GLY SER SER ASP SER GLN ILE LEU SEQRES 7 A 362 ASP LEU SER ASN ARG PHE TYR THR LEU ILE PRO HIS ASP SEQRES 8 A 362 PHE GLY MET LYS LYS PRO PRO LEU LEU ASN ASN ALA ASP SEQRES 9 A 362 SER VAL GLN ALA LYS VAL GLU MET LEU ASP ASN LEU LEU SEQRES 10 A 362 ASP ILE GLU VAL ALA TYR SER LEU LEU ARG GLY GLY SER SEQRES 11 A 362 ASP ASP SER SER LYS ASP PRO ILE ASP VAL ASN TYR GLU SEQRES 12 A 362 LYS LEU LYS THR ASP ILE LYS VAL VAL ASP ARG ASP SER SEQRES 13 A 362 GLU GLU ALA GLU ILE ILE ARG LYS TYR VAL LYS ASN THR SEQRES 14 A 362 HIS ALA THR THR HIS ASN ALA TYR ASP LEU GLU VAL ILE SEQRES 15 A 362 ASP ILE PHE LYS ILE GLU ARG GLU GLY GLU CYS GLN ARG SEQRES 16 A 362 TYR LYS PRO PHE LYS GLN LEU HIS ASN ARG ARG LEU LEU SEQRES 17 A 362 TRP HIS GLY SER ARG THR THR ASN PHE ALA GLY ILE LEU SEQRES 18 A 362 SER GLN GLY LEU ARG ILE ALA PRO PRO GLU ALA PRO VAL SEQRES 19 A 362 THR GLY TYR MET PHE GLY LYS GLY ILE TYR PHE ALA ASP SEQRES 20 A 362 MET VAL SER LYS SER ALA ASN TYR CYS HIS THR SER GLN SEQRES 21 A 362 GLY ASP PRO ILE GLY LEU ILE LEU LEU GLY GLU VAL ALA SEQRES 22 A 362 LEU GLY ASN MET TYR GLU LEU LYS HIS ALA SER HIS ILE SEQRES 23 A 362 SER LYS LEU PRO LYS GLY LYS HIS SER VAL LYS GLY LEU SEQRES 24 A 362 GLY LYS THR THR PRO ASP PRO SER ALA ASN ILE SER LEU SEQRES 25 A 362 ASP GLY VAL ASP VAL PRO LEU GLY THR GLY ILE SER SER SEQRES 26 A 362 GLY VAL ASN ASP THR SER LEU LEU TYR ASN GLU TYR ILE SEQRES 27 A 362 VAL TYR ASP ILE ALA GLN VAL ASN LEU LYS TYR LEU LEU SEQRES 28 A 362 LYS LEU LYS PHE ASN PHE LYS THR SER LEU TRP SEQRES 1 B 362 GLY PRO LEU THR VAL ASN PRO GLY THR LYS SER LYS LEU SEQRES 2 B 362 PRO LYS PRO VAL GLN ASP LEU ILE LYS MET ILE PHE ASP SEQRES 3 B 362 VAL GLU SER MET LYS LYS ALA MET VAL GLU TYR GLU ILE SEQRES 4 B 362 ASP LEU GLN LYS MET PRO LEU GLY LYS LEU SER LYS ARG SEQRES 5 B 362 GLN ILE GLN ALA ALA TYR SER ILE LEU SER GLU VAL GLN SEQRES 6 B 362 GLN ALA VAL SER GLN GLY SER SER ASP SER GLN ILE LEU SEQRES 7 B 362 ASP LEU SER ASN ARG PHE TYR THR LEU ILE PRO HIS ASP SEQRES 8 B 362 PHE GLY MET LYS LYS PRO PRO LEU LEU ASN ASN ALA ASP SEQRES 9 B 362 SER VAL GLN ALA LYS VAL GLU MET LEU ASP ASN LEU LEU SEQRES 10 B 362 ASP ILE GLU VAL ALA TYR SER LEU LEU ARG GLY GLY SER SEQRES 11 B 362 ASP ASP SER SER LYS ASP PRO ILE ASP VAL ASN TYR GLU SEQRES 12 B 362 LYS LEU LYS THR ASP ILE LYS VAL VAL ASP ARG ASP SER SEQRES 13 B 362 GLU GLU ALA GLU ILE ILE ARG LYS TYR VAL LYS ASN THR SEQRES 14 B 362 HIS ALA THR THR HIS ASN ALA TYR ASP LEU GLU VAL ILE SEQRES 15 B 362 ASP ILE PHE LYS ILE GLU ARG GLU GLY GLU CYS GLN ARG SEQRES 16 B 362 TYR LYS PRO PHE LYS GLN LEU HIS ASN ARG ARG LEU LEU SEQRES 17 B 362 TRP HIS GLY SER ARG THR THR ASN PHE ALA GLY ILE LEU SEQRES 18 B 362 SER GLN GLY LEU ARG ILE ALA PRO PRO GLU ALA PRO VAL SEQRES 19 B 362 THR GLY TYR MET PHE GLY LYS GLY ILE TYR PHE ALA ASP SEQRES 20 B 362 MET VAL SER LYS SER ALA ASN TYR CYS HIS THR SER GLN SEQRES 21 B 362 GLY ASP PRO ILE GLY LEU ILE LEU LEU GLY GLU VAL ALA SEQRES 22 B 362 LEU GLY ASN MET TYR GLU LEU LYS HIS ALA SER HIS ILE SEQRES 23 B 362 SER LYS LEU PRO LYS GLY LYS HIS SER VAL LYS GLY LEU SEQRES 24 B 362 GLY LYS THR THR PRO ASP PRO SER ALA ASN ILE SER LEU SEQRES 25 B 362 ASP GLY VAL ASP VAL PRO LEU GLY THR GLY ILE SER SER SEQRES 26 B 362 GLY VAL ASN ASP THR SER LEU LEU TYR ASN GLU TYR ILE SEQRES 27 B 362 VAL TYR ASP ILE ALA GLN VAL ASN LEU LYS TYR LEU LEU SEQRES 28 B 362 LYS LEU LYS PHE ASN PHE LYS THR SER LEU TRP HET SO4 A2015 5 HET SO4 A2016 5 HET GOL A2017 6 HET GOL A2018 6 HET FSU A2019 18 HET SO4 B2012 5 HET GOL B2013 6 HET SO4 B2014 5 HET FSU B2015 18 HETNAM SO4 SULFATE ION HETNAM GOL GLYCEROL HETNAM FSU 2-(3-METHOXYPROPYL)-3-OXO-2,3-DIHYDRO-1H-ISOINDOLE-4- HETNAM 2 FSU CARBOXAMIDE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 SO4 4(O4 S 2-) FORMUL 5 GOL 3(C3 H8 O3) FORMUL 7 FSU 2(C13 H16 N2 O3) FORMUL 12 HOH *146(H2 O) HELIX 1 1 PRO A 666 PHE A 677 1 12 HELIX 2 2 ASP A 678 TYR A 689 1 12 HELIX 3 3 PRO A 697 LEU A 701 5 5 HELIX 4 4 SER A 702 GLN A 722 1 21 HELIX 5 5 SER A 725 ILE A 740 1 16 HELIX 6 6 ASN A 754 GLY A 780 1 27 HELIX 7 7 ASP A 788 LYS A 796 1 9 HELIX 8 8 SER A 808 THR A 821 1 14 HELIX 9 9 GLY A 843 LYS A 849 1 7 HELIX 10 10 PRO A 850 LEU A 854 5 5 HELIX 11 11 ARG A 865 THR A 867 5 3 HELIX 12 12 ASN A 868 GLY A 876 1 9 HELIX 13 13 PRO A 885 TYR A 889 5 5 HELIX 14 14 MET A 900 ASN A 906 1 7 HELIX 15 15 TYR A 907 HIS A 909 5 3 HELIX 16 16 ASP A 993 ALA A 995 5 3 HELIX 17 17 PRO B 666 PHE B 677 1 12 HELIX 18 18 ASP B 678 TYR B 689 1 12 HELIX 19 19 PRO B 697 LEU B 701 5 5 HELIX 20 20 SER B 702 GLY B 723 1 22 HELIX 21 21 SER B 725 ILE B 740 1 16 HELIX 22 22 ASN B 754 GLY B 780 1 27 HELIX 23 23 ASP B 788 LYS B 798 1 11 HELIX 24 24 SER B 808 THR B 821 1 14 HELIX 25 25 GLY B 843 LYS B 849 1 7 HELIX 26 26 PRO B 850 LEU B 854 5 5 HELIX 27 27 ARG B 865 THR B 867 5 3 HELIX 28 28 ASN B 868 GLY B 876 1 9 HELIX 29 29 PRO B 885 TYR B 889 5 5 HELIX 30 30 MET B 900 TYR B 907 1 8 HELIX 31 31 PRO B 958 ASN B 961 5 4 HELIX 32 32 ASP B 993 ALA B 995 5 3 SHEET 1 AA 7 THR A 799 VAL A 803 0 SHEET 2 AA 7 TYR A 829 ARG A 841 -1 O LYS A 838 N LYS A 802 SHEET 3 AA 7 VAL A 997 PHE A1009 -1 O LYS A1000 N ILE A 839 SHEET 4 AA 7 ILE A 916 ALA A 925 -1 O GLY A 917 N LEU A1005 SHEET 5 AA 7 ARG A 857 SER A 864 -1 O ARG A 858 N VAL A 924 SHEET 6 AA 7 VAL A 967 VAL A 969 1 O ASP A 968 N LEU A 859 SHEET 7 AA 7 ILE A 962 LEU A 964 -1 O ILE A 962 N VAL A 969 SHEET 1 AB 4 ILE A 895 PHE A 897 0 SHEET 2 AB 4 GLU A 988 VAL A 991 -1 O TYR A 989 N PHE A 897 SHEET 3 AB 4 SER A 947 GLY A 950 -1 O VAL A 948 N ILE A 990 SHEET 4 AB 4 MET A 929 LEU A 932 1 O TYR A 930 N LYS A 949 SHEET 1 AC 3 GLY A 974 SER A 976 0 SHEET 2 AC 3 GLY A 952 PRO A 956 -1 O THR A 955 N ILE A 975 SHEET 3 AC 3 LEU A 984 TYR A 986 1 O LEU A 984 N LYS A 953 SHEET 1 BA 7 THR B 799 VAL B 803 0 SHEET 2 BA 7 TYR B 829 ARG B 841 -1 O LYS B 838 N LYS B 802 SHEET 3 BA 7 VAL B 997 PHE B1009 -1 O LYS B1000 N ILE B 839 SHEET 4 BA 7 ILE B 916 ALA B 925 -1 O GLY B 917 N LEU B1005 SHEET 5 BA 7 ARG B 857 SER B 864 -1 O ARG B 858 N VAL B 924 SHEET 6 BA 7 VAL B 967 VAL B 969 1 O ASP B 968 N LEU B 859 SHEET 7 BA 7 ILE B 962 LEU B 964 -1 O ILE B 962 N VAL B 969 SHEET 1 BB 4 ILE B 895 PHE B 897 0 SHEET 2 BB 4 GLU B 988 VAL B 991 -1 O TYR B 989 N PHE B 897 SHEET 3 BB 4 SER B 947 GLY B 950 -1 O VAL B 948 N ILE B 990 SHEET 4 BB 4 MET B 929 LEU B 932 1 O TYR B 930 N LYS B 949 SHEET 1 BC 3 GLY B 974 SER B 976 0 SHEET 2 BC 3 GLY B 952 PRO B 956 -1 O THR B 955 N ILE B 975 SHEET 3 BC 3 LEU B 984 TYR B 986 1 O LEU B 984 N LYS B 953 SITE 1 AC1 6 HOH A3008 LYS B 903 LEU B 984 LEU B 985 SITE 2 AC1 6 TYR B 986 GOL B2013 SITE 1 AC2 6 LYS A 903 LEU A 984 LEU A 985 TYR A 986 SITE 2 AC2 6 GOL A2018 HOH A3075 SITE 1 AC3 3 ARG A 858 MET A 929 LYS A 949 SITE 1 AC4 8 ASP A 766 ILE A 879 ALA A 880 TYR A 889 SITE 2 AC4 8 LYS A 893 GLY A 894 TYR A 896 HOH A3047 SITE 1 AC5 10 MET A 890 TYR A 896 LYS A 903 LEU A 984 SITE 2 AC5 10 GLU A 988 SO4 A2015 FSU A2019 HOH A3045 SITE 3 AC5 10 HOH A3052 HOH A3075 SITE 1 AC6 10 HOH A3008 MET B 890 TYR B 896 LYS B 903 SITE 2 AC6 10 TYR B 907 LEU B 984 GLU B 988 SO4 B2012 SITE 3 AC6 10 FSU B2015 HOH B3041 SITE 1 AC7 3 ARG B 858 MET B 929 LYS B 949 SITE 1 AC8 7 HIS A 862 GLY A 863 TYR A 896 PHE A 897 SITE 2 AC8 7 SER A 904 TYR A 907 GOL A2018 SITE 1 AC9 8 HIS B 862 GLY B 863 TYR B 896 PHE B 897 SITE 2 AC9 8 SER B 904 TYR B 907 GLU B 988 GOL B2013 CRYST1 179.900 54.050 92.760 90.00 113.79 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005559 0.000000 0.002450 0.00000 SCALE2 0.000000 0.018501 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011782 0.00000